Published Date: 02 Mar 2023
Acne can ruin a person's life. What is the real evidence for an effective treatment for different types of acne scars?
Read Full NewsA phase 2 study at CTAD 2025 explores VHB937's potential in treating early Alzheimer disease, focusing on safety and efficacy in patients.
In an analysis of the phase 2a CLEAR MIND study presented at CTAD 2025, laromestrocel treatment was associated with reduced hippocampal neuroinflammation in patients with mild Alzheimer disease.
A new phase 3 clinical trial is underway to evaluate masupirdine, a selective 5-HT6 receptor antagonist, as a potential treatment for agitation in patients with Alzheimer’s disease.
Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma
Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention
6 Ophthalmology Headlines You Missed in October 2025
1.
Early-Onset Colorectal Cancer in Male Veterans is Predicted by Risk Factors.
2.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
3.
Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.
4.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
5.
Psychiatric Disorders Are Common in Dementia Patients.
1.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
2.
Radiation in Oncology: Advances, Applications, and Accessibility
3.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
4.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
5.
Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation